Asha Ramanunni

1.5k total citations · 1 hit paper
14 papers, 1.1k citations indexed

About

Asha Ramanunni is a scholar working on Genetics, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Asha Ramanunni has authored 14 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Genetics, 7 papers in Immunology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Asha Ramanunni's work include Chronic Lymphocytic Leukemia Research (13 papers), Lymphoma Diagnosis and Treatment (5 papers) and Immune Cell Function and Interaction (4 papers). Asha Ramanunni is often cited by papers focused on Chronic Lymphocytic Leukemia Research (13 papers), Lymphoma Diagnosis and Treatment (5 papers) and Immune Cell Function and Interaction (4 papers). Asha Ramanunni collaborates with scholars based in United States, Taiwan and Poland. Asha Ramanunni's co-authors include John C. Byrd, Amy J. Johnson, Xiaoli Zhang, Kristie A. Blum, Amber Gordon, Joseph M. Flynn, Ahmed Hamdy, Sarah E. M. Herman, Joseph J. Buggy and Samantha Jaglowski and has published in prestigious journals such as Journal of Clinical Oncology, Blood and mAbs.

In The Last Decade

Asha Ramanunni

14 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Bruton tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765

2011 607 citations Sarah E. M. Herman, Amber Gordon et al. Blood profile →

Peers

Countries citing papers authored by Asha Ramanunni

Since Specialization

Citations

This map shows the geographic impact of Asha Ramanunni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Asha Ramanunni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Asha Ramanunni more than expected).

Fields of papers citing papers by Asha Ramanunni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Asha Ramanunni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Asha Ramanunni. The network helps show where Asha Ramanunni may publish in the future.

Co-authorship network of co-authors of Asha Ramanunni

This figure shows the co-authorship network connecting the top 25 collaborators of Asha Ramanunni. A scholar is included among the top collaborators of Asha Ramanunni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Asha Ramanunni. Asha Ramanunni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Targeted nanoparticle delivery overcomes off-target immunostimulatory effects of oligonucleotides and improves therapeutic efficacy in chronic lymphocytic leukemia 2012 ·Blood ·Bo Yu, Yicheng Mao, Li-Yuan Bai, Sarah E.M. Herman, Xinmei Wang, Asha Ramanunni, Yan Jin, Xiaokui Mo, Carolyn Cheney, Kenneth K. Chan, David Jarjoura, Guido Marcucci, Robert J. Lee, John C. Byrd, L. James Lee, Natarajan Muthusamy	58
2	Enhanced detection of chromosomal abnormalities in chronic lymphocytic leukemia by conventional cytogenetics using CpG oligonucleotide in combination with pokeweed mitogen and phorbol myristate acetate 2011 ·Cancer Genetics ·Natarajan Muthusamy, (unknown), Leslie A. Andritsos, Joseph M. Flynn, Jeffrey A. Jones, Asha Ramanunni, Xiaokui Mo, David Jarjoura, John C. Byrd, Nyla A. Heerema	27
3	Bruton tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765 breakdown → 2011 ·Blood ·Sarah E. M. Herman, Amber Gordon, Erin Hertlein, Asha Ramanunni, Xiaoli Zhang, Samantha Jaglowski, Joseph M. Flynn, Jeffrey J. Jones, Kristie A. Blum, Joseph J. Buggy, Ahmed Hamdy, Amy J. Johnson, John C. Byrd	607
4	The role of phosphatidylinositol 3-kinase-δ in the immunomodulatory effects of lenalidomide in chronic lymphocytic leukemia 2011 ·Blood ·Sarah E.M. Herman, Rosa Lapalombella, Amber Gordon, Asha Ramanunni, Kristie A. Blum, Jeffrey A. Jones, Xiaoli Zhang, Brian J. Lannutti, Kamal D. Puri, Natarajan Muthusamy, John C. Byrd, Amy J. Johnson	81
5	CRM1/XPO1 Represents a Promising Therapeutic Target for Treatment of Chronic Lymphocytic Leukemia 2011 ·Blood ·Rosa Lapalombella, Caroline Berglund, Emilia Mahoney, Katie Williams, Shruti Jha, Asha Ramanunni, Vincent Sandanayaka, Sharon Shechter, Dilara McCauley, Sharon Shacham, Michael Kauffman, John C. Byrd	3
6	Tetraspanin CD37 Directly Mediates Transduction of Survival and Apoptotic Signals 2011 ·Blood ·Rosa Lapalombella, Asha Ramanunni, Yuh-Ying Yeh, Liwen Wang, Shruti Jha, (unknown), Sarah E.M. Herman, Leslie A. Andritsos, Jeffrey A. Jones, Joseph M. Flynn, Xiaokui Mo, Amy J. Johnson, Peter M. Thompson, Paul A. Algate, Scott Stromatt, Michael A. Freitas, Natarajan Muthusamy, John C. Byrd	4
7	Differential effects of IL-2 and IL-21 on expansion of the CD4⁺CD25⁺Foxp3⁺T regulatory cells with redundant roles in natural killer cell mediated antibody dependent cellular cytotoxicity in chronic lymphocytic leukemia 2010 ·mAbs ·Aruna Gowda, Asha Ramanunni, Carolyn Cheney, Darlene M. Rozewski, Wayne Kindsvogel, Amy Lehman, David Jarjoura, Michael A. Caligiuri, John C. Byrd, Natarajan Muthusamy	24
8	Liposomal Targeted Delivery Overcomes Immunostimulatory Effects of Oligonucleotide Based Therapy In Chronic Lymphocytic Leukemia. 2010 ·Blood ·Bo Yu, Yicheng Mao, Li‐Yuan Bai, Sarah E.M. Herman, Asha Ramanunni, Yan Jin, Xiaokui Mo, Carolyn Cheney, Kenneth K. Chan, David Jarjoura, Guido Marcucci, Robert J. Lee, L.James Lee, John C. Byrd, Natarajan Muthusamy	7
9	Lenalidomide treatment promotes CD154 expression on CLL cells and enhances production of antibodies by normal B cells through a PI3-kinase–dependent pathway 2009 ·Blood ·Rosa Lapalombella, Leslie A. Andritsos, Qing Liu, Sarah May, (unknown), Lan V. Pham, Kristie A. Blum, William Blum, Asha Ramanunni, Chelsey A. Raymond, Lisa L. Smith, Amy Lehman, Xiaokui Mo, David Jarjoura, Ching-Shih Chen, R. Ford, Christoph Rader, Natarajan Muthusamy, Amy J. Johnson, John C. Byrd	92
10	Effect of CD37 small modular immuno-pharmaceutical (SMIP) on direct apoptosis in chronic lymphocytic leukemia cells via transcriptional up-regulation of the BH3 family member BIM 2009 ·Journal of Clinical Oncology ·John C. Byrd, Rosa Lapalombella, Asha Ramanunni, Leslie A. Andritsos, James M. Flynn, Peter Baum, P. D. Thompson, Natarajan Muthusamy	4
11	Lenalidomide down-regulates the CD20 antigen and antagonizes direct and antibody-dependent cellular cytotoxicity of rituximab on primary chronic lymphocytic leukemia cells 2008 ·Blood ·Rosa Lapalombella, Bo Yu, Georgia Triantafillou, Qing Liu, Jonathan P. Butchar, Gerard Lozanski, Asha Ramanunni, Lisa L. Smith, William Blum, Leslie A. Andritsos, Da-Sheng Wang, Amy Lehman, Ching-Shih Chen, Amy J. Johnson, Guido Marcucci, Robert J. Lee, (unknown), Susheela Tridandapani, Natarajan Muthusamy, John C. Byrd	83
12	IL-21 mediates apoptosis through up-regulation of the BH3 family member BIM and enhances both direct and antibody-dependent cellular cytotoxicity in primary chronic lymphocytic leukemia cells in vitro 2008 ·Blood ·Aruna Gowda, Julie M. Roda, Syed-Rehan A. Hussain, Asha Ramanunni, Trupti Joshi, (unknown), Xiaoli Zhang, Amy Lehman, David Jarjoura, William E. Carson, Wayne Kindsvogel, Carolyn Cheney, Michael A. Caligiuri, Susheela Tridandapani, Natarajan Muthusamy, John C. Byrd	81
13	IL-21 Promotes Apoptosis through Induction of the BH3 Only Protein Bim and Enhacnes Direct and Innate Immune-Promoted Death of Chronic Lymphocytic Leukemia Cells. 2007 ·Blood ·Julie M. Roda, Aruna Gowda, Rehan M. Hussain, Asha Ramanunni, Amy Lehman, Wayne Kindsvogel, William E. Carson, Natarajan Muthusamy, John C. Byrd	1
14	IL-21 enhances chemoimmunotherapy mediated death of chronic lymphocytic leukemia cells 2007 ·Journal of Clinical Oncology ·Aruna Gowda, Asha Ramanunni, Carolyn Cheney, Julie M. Roda, Wayne Kindsvogel, (unknown), (unknown), William E. Carson, Natarajan Muthusamy, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact